, , , et al. . ;(suppl 1):S81–S92.1. ER Dubberke DN Gerding D Classen Strategies to prevent infections in acute care hospitalsClostridium difficile Infect Control Hosp Epidemiol 2008 29
, , , et al. .” ;():–.2. DS Yokoe DJ Anderson SM Berenholtz Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates Infect Control Hosp Epidemiol 2014 35 5 455459
, , . . ;():–.3. LC McDonald M Owings DB Jernigan infection in patients discharged from US short-stay hospitals, 1996–2003Clostridium difficile Emerg Infect Dis 2006 12 3 409415
, , , . . ;():–.4. BA Miller LF Chen DJ Sexton DJ Anderson Comparison of the burdens of hospital-onset, healthcare facility–associated infection and of healthcare-associated infection due to methicillin-resistant in community hospitalsClostridium difficileStaphylococcus aureus Infect Control Hosp Epidemiol 2011 32 4 387390
, , . . ;():–.5. MD Zilberberg AF Shorr MH Kollef Growth and geographic variation in hospitalizations with resistant infections, United States, 2000–2005 Emerg Infect Dis 2008 14 11 17561758
, , , et al. . ;():–.7. MP Bauer DW Notermans BH van Benthem infection in Europe: a hospital-based surveyClostridium difficile Lancet 2011 377 9759 6373
, , , et al. . ;():–.8. VG Loo L Poirier MA Miller A predominantly clonal multi-institutional outbreak of –associated diarrhea with high morbidity and mortalityClostridium difficile N Engl J Med 2005 353 23 24422449
, , , et al. . ;():–.9. M Miller D Gravel M Mulvey Health care–associated infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortalityClostridium difficile Clin Infect Dis 2010 50 2 194201
, , , et al. . ;():–.10. DM Denno N Shaikh JR Stapp Diarrhea etiology in a pediatric emergency department: a case control study Clin Infect Dis 2012 55 7 897904
, , , . . ;():–.11. RE Feghaly JL Stauber PI Tarr DB Haslam Viral co-infections are common and are associated with higher bacterial burden in children with infectionClostridium difficile J Pediatr Gastroenterol Nutr 2013 57 6 813816
, , , , , . . ;():–.12. C Rousseau I Poilane L De Pontual AC Maherault A Le Monnier A Collignon carriage in healthy infants in the community: a potential reservoir for pathogenic strainsClostridium difficile Clin Infect Dis 2012 55 9 12091215
, , , , , . . ;():–.15. ER Dubberke KA Reske Y Yan MA Olsen LC McDonald VJ Fraser –associated disease in a setting of endemicity: identification of novel risk factorsClostridium difficile Clin Infect Dis 2007 45 12 15431549
, , , et al. . ;():–.17. J Kim JF Shaklee S Smathers Risk factors and outcomes associated with severe infection in childrenClostridium difficile Pediatr Infect Dis J 2012 31 2 134138
, , , et al. . ;():–.19. LC McDonald GE Killgore A Thompson An epidemic, toxin gene–variant strain of Clostridium difficile N Engl J Med 2005 353 23 24332441
, , , . . ;():e24894.20. DA Burns D Heeg ST Cartman NP Minton Reconsidering the sporulation characteristics of hypervirulent BI/NAP1/027Clostridium difficile PLoS ONE 2011 6 9
, , , et al. . ;():–.21. M Merrigan A Venugopal M Mallozzi Human hypervirulent strains exhibit increased sporulation as well as robust toxin productionClostridium difficile J Bacteriol 2010 192 19 49044911
, , , et al. . ;():–.22. M Warny J Pepin A Fang Toxin production by an emerging strain of associated with outbreaks of severe disease in North America and EuropeClostridium difficile Lancet 2005 366 9491 10791084
, , , et al. . ;():–.23. AS Walker DW Eyre DH Wyllie Relationship between bacterial strain type, host biomarkers, and mortality in infectionClostridium difficile Clin Infect Dis 2013 56 11 15891600
, , , et al. . ;():–.25. AK Cheknis SP Sambol DM Davidson Distribution of strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005–2007Clostridium difficile Anaerobe 2009 15 6 230233
, , , et al. . ;():–.27. ER Dubberke AM Butler KA Reske Attributable outcomes of endemic –associated disease in nonsurgical patientsClostridium difficile Emerg Infect Dis 2008 14 7 10311038
, . . ;(suppl 2):S88–S92.28. ER Dubberke MA Olsen Burden of on the healthcare systemClostridium difficile Clin Infect Dis 2012 55
, , , , . . ;():–.29. AJ Hall AT Curns LC McDonald UD Parashar BA Lopman The roles of and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007Clostridium difficile Clin Infect Dis 2012 55 2 216223
, , , , . . ;():–.30. JS Sammons R Localio R Xiao SE Coffin T Zaoutis infection is associated with increased risk of death and prolonged hospitalization in childrenClostridium difficile Clin Infect Dis 2013 57 1 18
, , , et al. . ;():–.31. J Pepin N Saheb MA Coulombe Emergence of fluoroquinolones as the predominant risk factor for –associated diarrhea: a cohort study during an epidemic in QuebecClostridium difficile Clin Infect Dis 2005 41 9 12541260
, , , . . ;():–.32. S Dial JA Delaney AN Barkun S Suissa Use of gastric acid–suppressive agents and the risk of community-acquired –associated diseaseClostridium difficile JAMA 2005 294 23 29892995
, , , , , . . ;():–.33. J Belmares DN Gerding JP Parada S Miskevics F Weaver S Johnson Outcome of metronidazole therapy for disease and correlation with a scoring systemClostridium difficile J Infect 2007 55 6 495501
, , , et al. . ;():–.34. DM Musher S Aslam N Logan Relatively poor outcome after treatment of colitis with metronidazoleClostridium difficile Clin Infect Dis 2005 40 11 15861590
, , , . . ;():–.35. FA Zar SR Bakkanagari KM Moorthi MB Davis A comparison of vancomycin and metronidazole for the treatment of –associated diarrhea, stratified by disease severityClostridium difficile Clin Infect Dis 2007 45 3 302307
, , . . ;(suppl ):–.36. EJ Kuijper B Coignard P Tull Emergence of –associated disease in North America and EuropeClostridium difficile Clin Microbiol Infect 2006 12 6 218
, , , et al. . ;():–.38. ER Dubberke Z Han L Bobo Impact of clinical symptoms on interpretation of diagnostic assays for infectionsClostridium difficile J Clin Microbiol 2011 49 8 28872893
, , . . ;():–.39. J Pepin L Valiquette B Cossette Mortality attributable to nosocomial –associated disease during an epidemic caused by a hypervirulent strain in QuebecClostridium difficile CMAJ 2005 173 9 10371042
, , , et al. . ;():–.41. Y Longtin S Trottier G Brochu Impact of the type of diagnostic assay on infection and complication rates in a mandatory reporting programClostridium difficile Clin Infect Dis 2013 56 1 6773
, , , et al. . ;():–.42. TD Planche KA Davies PG Coen Differences in outcome according to testing method: a prospective multicentre diagnostic validation study of C difficile infectionClostridium difficile Lancet Infect Dis 2013 13 11 936945
, , , . . ;():–.43. ER Dubberke KA Reske LC McDonald VJ Fraser ICD-9 codes and surveillance for –associated diseaseClostridium difficile Emerg Infect Dis 2006 12 10 15761579
, , , , , . . ;():–.46. CR Polage DL Chin JL Leslie J Tang SH Cohen JV Solnick Outcomes in patients tested for toxinsClostridium difficile Diagn Microbiol Infect Dis 2012 74 4 369373
, , . . ;():–.49. MP Bauer EJ Kuijper JT van Dissel European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for infection (CDI)Clostridium difficile Clin Microbiol Infect 2009 15 12 10671079
, , , et al. . ;():–.51. CM Surawicz LJ Brandt DG Binion Guidelines for diagnosis, treatment, and prevention of infectionsClostridium difficile Am J Gastroenterol 2013 108 4 478498
, , , et al. . ;():–.53. SP Stone BS Cooper CC Kibbler The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection Lancet Infect Dis 2007 7 4 282288
, , , et al. . ;():–.54. S Fowler A Webber BS Cooper Successful use of feedback to improve antibiotic prescribing and reduce infection: a controlled interrupted time seriesClostridium difficile J Antimicrob Chemother 2007 59 5 990995
, , , , . . ;(suppl ):–.55. L Valiquette B Cossette MP Garant H Diab J Pepin Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of –associated disease caused by the hypervirulent NAP1/027 strainClostridium difficile Clin Infect Dis 2007 45 2 S112S121
, , , et al. . ;():–.56. MA Aldeyab MP Kearney MG Scott An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of infection in hospital settingsClostridium difficile J Antimicrob Chemother 2012 67 12 29882996
, , , . . ;():–.57. MJ Talpaert RG Gopal BS Cooper P Wade Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of infectionClostridium difficile J Antimicrob Chemother 2011 66 9 21682174
, , , , , . . ;():–.58. DM Guerrero MM Nerandzic LA Jury S Jinno S Chang CJ Donskey Acquisition of spores on gloved hands after contact with the skin of patients with infection and with environmental surfaces in their roomsClostridium difficile Am J Infect Control 2012 40 6 556558
, , , . . ;():–.59. LV McFarland ME Mulligan RY Kwok WE Stamm Nosocomial acquisition of infectionClostridium difficile N Engl J Med 1989 320 4 204210
, , , , . . ;():–.63. RG Gopal A Jeanes M Osman C Aylott J Green Marketing hand hygiene in hospitals—a case study J Hosp Infect 2002 50 1 4247
, , , et al. . ;():–.66. N Knight T Strait N Anthony colitis: a retrospective study of incidence and severity before and after institution of an alcohol-based hand rub policyClostridium difficile Am J Infect Control 2010 38 7 523528
, , , , , . . ;():–.68. N Vernaz H Sax D Pittet P Bonnabry J Schrenzel S Harbarth Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile J Antimicrob Chemother 2008 62 3 601607
, . . ;():–.70. VT Chang K Nelson The role of physical proximity in nosocomial diarrhea Clin Infect Dis 2000 31 3 717722
, , , , . . ;():–.71. CR Clabots S Johnson MM Olson LR Peterson DN Gerding Acquisition of by hospitalized patients: evidence for colonized new admissions as a source of infectionClostridium difficile J Infect Dis 1992 166 3 561567
, , De, , . . ;():–.72. MH Samore L Venkataraman PC Girolami RD Arbeit AW Karchmer Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial diarrheaClostridium difficile Am J Med 1996 100 1 3240
, , , . . ;():–.74. JL Mayfield T Leet J Miller LM Mundy Environmental control to reduce transmission of Clostridium difficile Clin Infect Dis 2000 31 4 9951000
, , , , , . . ;():–.75. MH Wilcox WN Fawley N Wigglesworth P Parnell P Verity J Freeman Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of infectionClostridium difficile J Hosp Infect 2003 54 2 109114
. . ;():–.76. AE Simor Diagnosis, management, and prevention of infection in long-term care facilities: a reviewClostridium difficile J Am Geriatr Soc 2010 58 8 15561564
, , , et al. . ;():–.78. VG Loo AM Bourgault L Poirier Host and pathogen factors for infection and colonizationClostridium difficile N Engl J Med 2011 365 18 16931703
, , , . ? ;():–.79. SB Doernberg LG Winston DH Deck HF Chambers Does doxycycline protect against development of infectionClostridium difficile Clin Infect Dis 2012 55 5 615620
, , , , , . . ;():–.80. F Le V Arora DN Shah M Salazar HR Palmer KW Garey A real-world evaluation of oral vancomycin for severe infection: implications for antibiotic stewardship programsClostridium difficile Pharmacotherapy 2012 32 2 129134
, , , , . . ;():–.81. SE Harpe TJ Inocencio AL Pakyz MJ Oinonen RE Polk Characterization of continued antibacterial therapy after diagnosis of hospital-onset infection: implications for antimicrobial stewardshipClostridium difficile Pharmacotherapy 2012 32 8 744754
, , , et al. . ;():–.84. ER Dubberke KA Reske J Noble-Wang Prevalence of environmental contamination and strain variability in multiple health care facilitiesClostridium difficile Am J Infect Control 2007 35 5 315318
III, , , . . ;():–.85. DM Dumford MM Nerandzic BC Eckstein CJ Donskey What is on that keyboard? detecting hidden environmental reservoirs of during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strainsClostridium difficile Am J Infect Control 2009 37 1 1519
, , . . ;():–.86. AM Lewis J Gammon I Hosein The pros and cons of isolation and containment J Hosp Infect 1999 43 1 1923
, , . . ;():–.91. PC Carling MF Parry SM Von Beheren Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals Infect Control Hosp Epidemiol 2008 29 1 17
, , . . ;():–.93. MH Wilcox WN Fawley P Parnell Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile J Hosp Infect 2000 44 1 6569
, , , et al. . ;():–.100. C McNulty M Logan IP Donald Successful control of infection in an elderly care unit through use of a restrictive antibiotic policyClostridium difficile J Antimicrob Chemother 1997 40 5 707711
, , , , . . ;():–.101. SM Pear TH Williamson KM Bettin DN Gerding JN Galgiani Decrease in nosocomial –associated diarrhea by restricting clindamycin useClostridium difficile Ann Intern Med 1994 120 4 272277
, , , et al. . ;():–.102. S Johnson SR Homann KM Bettin Treatment of asymptomatic carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trialClostridium difficile Ann Intern Med 1992 117 4 297302
, . . ;():–.103. KB Kirkland JM Weinstein Adverse effects of contact isolation Lancet 1999 354 9185 11771178
, , , . . ;():–.104. DJ Morgan DJ Diekema K Sepkowitz EN Perencevich Adverse outcomes associated with contact precautions: a review of the literature Am J Infect Control 2009 37 2 8593
, , , . . ;():–.105. S Saint LA Higgins BK Nallamothu C Chenoweth Do physicians examine patients in contact isolation less frequently? a brief report Am J Infect Control 2003 31 6 354356
, , . . ;():–.106. HT Stelfox DW Bates DA Redelmeier Safety of patients isolated for infection control JAMA 2003 290 14 18991905
, , . . ;():–.107. LV McFarland GW Elmer CM Surawicz Breaking the cycle: treatment strategies for 163 cases of recurrent diseaseClostridium difficile Am J Gastroenterol 2002 97 7 17691775
, , , . . ;( suppl 2):–.108. JD Siegel E Rhinehart M Jackson L Chiarello 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings Am J Infect Control 2007 35 10 S65S164
, , , et al. . ;:CD006095.109. JZ Goldenberg SS Ma JD Saxton Probiotics for the prevention of –associated diarrhea in adults and childrenClostridium difficile Cochrane Database Syst Rev 2013 5
, , , et al. . ;():–.110. BC Johnston SS Ma JZ Goldenberg Probiotics for the prevention of –associated diarrhea: a systematic review and meta-analysisClostridium difficile Ann Intern Med 2012 157 12 878888
, , , et al. . ;():–.113. SJ Allen K Wareham D Wang Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trialClostridium difficile Lancet 2013 382 9900 12491257
, , , et al. . ;():–.114. P Munoz E Bouza M Cuenca-Estrella fungemia: an emerging infectious diseaseSaccharomyces cerevisiae Clin Infect Dis 2005 40 11 16251634
, , , , , . . ;():–.116. SK Wong A Kneebone M Morgan CJ Henderson A Morgan B Jalaludin Surgical management of colorectal cancer in south-western Sydney 1997–2001: a prospective series of 1293 unselected cases from six public hospitals ANZ J Surg 2005 75 9 776782
, , , , . . ;():–.119. JE Farley D Doughman R Jeeva P Jeffries JM Stanley Department of Health and Human Services releases new immersive simulation experience to improve infection control knowledge and practices among health care workers and students Am J Infect Control 2012 40 3 258259
, , , . . ;(4 suppl 1):S11–S17.120. T Landers S Abusalem MB Coty J Bingham Patient-centered hand hygiene: the next step in infection prevention Am J Infect Control 2012 40
. ? ;(suppl ):–.121. ER Dubberke Prevention of healthcare-associated infection: what worksClostridium difficile Infect Control Hosp Epidemiol 2010 31 1 S38S41
, , , et al. . ;():–.122. GH Guyatt AD Oxman GE Vist GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 2008 336 7650 924926
